Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Management of vasoocclusive crises in sickle cell disease patients

Management of vasoocclusive crises in sickle cell disease patients

Badianjile, Moses

Paperback

Medical Reference

ISBN10: 6208627265
ISBN13: 9786208627263
Publisher: Our Knowledge Publishing
Published: Feb 11 2025
Pages: 64
Weight: 0.22
Height: 0.15 Width: 6.00 Depth: 9.00
Language: English
This was a 12-month documentary and retrospective study carried out in a pediatric setting in Kinshasa. The general objective was to evaluate the method of pain treatment by analgesic steps recommended by the World Health Organization (WHO) in the painful sickle-cell crisis. The study involved 220 sickle-cell patients of both sexes, aged between 6 months and 17 years, undergoing a painful crisis. Treatment duration averaged 5 days, depending on the severity of painful symptoms. Pain intensity was assessed using VAS (visual analogue scale) and DEGR (pain enfant Goustave Roussy) scales.The effectiveness of analgesic treatment was systematically assessed at 2 hours. The 6-10 age group was the most affected, with 40%. In 52.27% of cases, pain was soothed by a Tier I analgesic (Paracetamol), while 47.73% required a switch to Tier II (Temgesic).

Also from

Badianjile, Moses

View All

Also in

Medical Reference

View All